Event Announcement: Xcelerating Life Sciences San Diego

Xconomy

Can’t make the San Diego. National National blog main National top stories San Diego San Diego blog main San Diego top stories Biotech Life Sciences XconSD

Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report

Xconomy

Learn what’s fueling San Diego’s biotech investment and partnership opportunities by downloading Xconomy’s new special report and podcast that package the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine & Genomics event.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in

Xconomy

Our new podcast packages the highlights from the recent Xcelerating Life Sciences San Diego: Biomedical Breakthroughs in Precision Medicine & Genomics forum. How has the investment paradigm shift in funding strategies impacted San Diego?

San Diego Tech Roundup: Ezoic, Trust & Will, Oska Wellness & More

Xconomy

Summer can be a slow time in San Diego, but its startups have stayed busy. Sageview Capital, an investment firm with offices in Palo Alto, CA, and in Greenwich, CT, was the lone investor that participated in the deal. Based in Carlsbad, in northern San Diego County, Ezoic launched its platform in 2011. Denny Sanford Tech Tech Coast Angels Trust & Will UC San Diego University of San Diego

Xcelerating Life Sciences San Diego Will Be Delivered Digitally

Xconomy

At Xconomy, we are here to serve the global biotech community and help biotech and pharma companies connect, do business, and find investment opportunities.

33 Tech Startups Make San Diego Venture Group “Cool Companies” List

Xconomy

In the eyes of the San Diego Venture Group, the key element is readiness for venture capital backing. What does it take for a tech startup to be considered “cool?”

San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis

Xconomy

Molecular Assemblies , a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round.

Why Comma.ai, Maker of Self-Driving Tech, is Moving to San Diego

Xconomy

San Diego’s startup community has rejoiced in recent months as massive companies that employ thousands of engineers—including Amazon (NASDAQ: AMZN ), Apple (NASDAQ: AAPL ), and the tech arm of Walmart (NYSE: WMT )—have announced expansions in the region. Local entrepreneurs hope that investment will make other tech businesses, including early-stage companies, more comfortable settling in the region, where concerns about talent recruitment are long-standing.

$100M Round Turns San Diego’s Seismic into Region’s Newest Unicorn

Xconomy

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors.

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Xconomy

Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM ) struck a deal to raise up to $80 million in a private placement. The company closed the first $30 million, from Nevada-based investment firm PDL BioPharma (NASDAQ: PDLI ), on Wednesday, with the firm paying a 26.4 Locally based biotech companies receive fresh funding from investors.

Plug and Play San Diego Finds Home in New Downtown Works Space

Xconomy

Plug and Play San Diego has formed a partnership with Downtown Works, a new co-working space in downtown San Diego, which will give the local Plug and Play program a place to call home.

San Diego Life Science Companies See Stock Bumps, Slips in JPM Wake

Xconomy

Morgan Healthcare Conference started out as a clubby get-together hosted by investment bank Hambrecht & Quist. Back in the days of H&Q, bankers and entrepreneurs flocked to San Francisco to get information about biotech companies that was otherwise hard to come by.

Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference

Xconomy

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Join Xconomy as we explore how the investment paradigm shift in funding strategies has impacted San Diego, the future for precision medicine, the growth of genomics, and more.

Xconomy Guide to Best Sessions at Startup Week San Diego

Xconomy

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. This year’s Startup Week also has added five new tracks intended to highlight San Diego’s strengths as a startup ecosystem.

Walmart: Turning San Diego Into A Key Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego? How long has Walmart had an office in San Diego? How did Walmart decide to set up in San Diego?

Walmart: Turning San Diego Into Its Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego? How long has Walmart had an office in San Diego? How did Walmart decide to set up in San Diego?

Big VCs Join Xconomy in San Diego to Discuss Big Data, Big Biology

Xconomy

In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer.

Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq

Xconomy

COVID-19 has ravaged the economy, and it was expected to quash the IPO market, too. But the biotech sector is defying the pandemic with crossover financings and freshly minted public companies.

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. million in a Series D round of investment capital, according to founder and chairman Tony Farwell.

San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals

Xconomy

Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. VC firms invested $280.6 million in 49 startups in San Diego County during the third quarter, according to a breakout of data provided by PitchBook as part of the inaugural “Venture Monitor” report. San Diego. $35

San Diego VC Funding Hits $547.2M in Q1; Ideaya Leads Top 10 Deals

Xconomy

million into 37 startup companies throughout San Diego County during the first three months of 2018, maintaining roughly the same level of venture funding seen in recent quarters, according to the Venture Monitor Report. The amount of capital invested in the San Diego area was up slightly from the $541.2 million invested during the final three months of 2017, according to Venture Monitor data. million invested in the first quarter last year.

Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19)

Xconomy

The start of a potentially big biomedical breakthrough is blooming within all of us. Drug research aiming to turn bacteria into microbiome therapies now spans programs aiming to address gut disorders, autism, cancer, and more.

Class 109

First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals

Xconomy

Thirty-seven venture-backed companies in the San Diego area collected almost $350 million in new funding during the first three months of 2017, according to data released this week as part of the latest Venture Monitor report from the National Venture Capital Association and Seattle-based PitchBook. million that VCs invested in San Diego startups in the same quarter in 2016, and off nearly 17 percent from the $420.3 billion invested.

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. San Diego.

Profitability Helps San Diego Lender Step Out from Industry Cloud

Xconomy

In contrast to some alternative lenders, the San Diego firm said it is growing fast and is consistently profitable. Problems at one industry leader, San Francisco-based LendingClub (NYSE: LC ), have added to waning enthusiasm among some investors for the peer-to-peer model, which matches online users who want a loan with Wall Street investors or wealthy individuals looking for a higher rate of return than many traditional, fixed-income investments.

Under New Ownership, San Diego’s Ad-Juster Names Dennis Clerke CEO

Xconomy

Ad-Juster, a San Diego adtech startup acquired earlier this year by the investment arm of China’s Innotech International Group, Wednesday named local software entrepreneur Dennis Clerke as CEO. Clerke (a San Diego Xconomist) was previously the CEO of Sunnyvale, CA-based NetSeer, an adtech acquired in February by Inuvo (NYSE: INUV , an advertising technology and digital publishing company based in Little Rock, AR.

San Diego VC Funding at $426.6M in Third Quarter; Plus Top 10 Deals

Xconomy

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. Altogether, venture firms invested. As Xconomy reported in July, Brain Corp. raised $114 million in a Series C funding round led by Softbank’s new $100 billion Vision Fund.

Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More

Xconomy

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won’t truly return to anything resembling a pre-pandemic normal without a COVID-19 vaccine.

Study 70

Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M

Xconomy

Now the San Diego-based company has added $53 million to a round of funding it first closed in 2017, money that it plans to put toward continued evaluation of the investigational antifungal treatment, fosmanogepix.

Study 72

EvoNexus Gets Bank, Investment Firm Backing for Fintech Incubator

Xconomy

Two financial firms are betting on a nonprofit incubator program in San Diego in hopes of identifying top talent and potential targets for investment or acquisition.

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy

News 57

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More

Xconomy

Finding and enrolling patients for clinical trials is always challenging. The coronavirus pandemic has made it nearly impossible.

Study 80

At Venture Summit, 3 Takeaways For Entrepreneurs From True Ventures’ Phil Black

Xconomy

No one would argue that San Diego is overflowing with venture capitalists in the way, say, the San Francisco Bay Area is. Venture Summit —an annual gathering of local founders seeking financing and venture investors, primarily from outside San Diego, on the hunt for companies to back—was first organized by the San Diego Venture Group (SDVG) 17 years ago.

Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments

Xconomy

A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA.

Guide 82

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More

Xconomy

Flagship CEO Noubar Afeyan told Xconomy that the pandemic unexpectedly highlights the need for investment in one of its new thematic areas of interest: “health security” tools and technologies to prevent, detect, and delay disease.

Tool 74

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Xconomy

EvoFem (NASDAQ: EVFM )—and the rest of the women’s health sector—will know by midyear whether the product will be approved, making the San Diego companies one of the few biotechs to commercialize a novel prescription women’s health product in recent years.

Record Exit Value for VC-Backed Startups Could Fuel Investment

Xconomy

billion in money returned to investors—that’s already topped all other full-year totals, according to the latest VentureMonitor, the quarterly report on venture capital investment complied by the National Venture Capital Association and PitchBook.

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

It will be hard to top last year’s flurry of biotech companies joining the public markets, but this week is shaping up to be the busiest for life science IPOs in recent memory. Five biotechs priced their IPOs and at least one more is coming.

Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More

Xconomy

Alexion Pharmacueticals CEO Ludwig Hantson has made no secret that he wants to diversify his company’s drug portfolio and he has shown willingness to open the corporate checkbook to accomplish that goal.

Biopharma Execs Remain Optimistic Despite Political Headwinds

Xconomy

These are among the major findings of a survey of 500 industry leaders and investors conducted by investment bank Jefferies. Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night.

Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More

Xconomy

Startups are raising money, and there is more financing on the way as investment firms close new funds. The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector.

Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M

Xconomy

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 In the nucleus of human cells sit our chromosomes, comprised mainly of tightly wound DNA.

Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More

Xconomy

Clinical trials have historically hewn to a rigid format. A trial is designed, conducted according to that design, and then results are analyzed. Making changes in the midst of the study was a no-no.

News 76